Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Dawidowicz

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Medicina (Kaunas, Lithuania)|January 21, 2022
Periostin in Angiogenesis and Inflammation in CRC-A Preliminary Observational StudyAgnieszka Kula, Miriam Dawidowicz, Sylwia Mielcarska, et al.
Cells|April 11, 2025
B7H3 in Gastrointestinal Tumors: Role in Immune Modulation and Cancer Progression: A Review of the LiteratureSylwia Mielcarska, Anna Kot, Agnieszka Kula, et al.
Medicina (Kaunas, Lithuania)|February 25, 2022
Assessment of the RANTES Level Correlation and Selected Inflammatory and Pro-Angiogenic Molecules Evaluation of Their Influence on CRC Clinical Features: A Preliminary Observational StudySylwia Mielcarska, Agnieszka Kula, Miriam Dawidowicz, et al.
Current Medical Science|June 25, 2021
GDF-15 Level Correlates with CMKLR1 and VEGF-A in Tumor-free Margin in Colorectal CancerSylwia Mielcarska, Kamila Stopińska, Miriam Dawidowicz, et al.
International Journal of Molecular Sciences|January 28, 2026
Association of TIGIT and CD155 with KRAS, NRAS, BRAF, PIK3CA, and AKT Gene Mutations, MSI Status, and Cytokine Profiles in Colorectal CancerBłażej Ochman, Piotr Limanówka, Sylwia Mielcarska, et al.
International Journal of Molecular Sciences|July 29, 2025
TIM-3/Galectin-9 Immune Axis in Colorectal Cancer in Relation to KRAS, NRAS, BRAF, PIK3CA, AKT1 Mutations, MSI Status, and the Cytokine MilieuBłażej Ochman, Anna Kot, Sylwia Mielcarska, et al.
Experimental and Molecular Pathology|January 14, 2020
Assessment of CMKLR1 level in colorectal cancer and its correlation with angiogenic markersPaweł Kiczmer, Alicja Prawdzic Seńkowska, Agnieszka Kula, et al.
Current Issues in Molecular Biology|May 15, 2023
Do Elevated YKL-40 Levels Drive the Immunosuppressive Tumor Microenvironment in Colorectal Cancer? Assessment of the Association of the Expression of YKL-40, MMP-8, IL17A, and PD-L1 with Coexisting Type 2 Diabetes, Obesity, and Active SmokingBłażej Ochman, Sylwia Mielcarska, Agnieszka Kula, et al.
Current Issues in Molecular Biology|December 27, 2024
Association of SIGLEC9 Expression with Cytokine Expression, Tumor Grading, KRAS, NRAS, BRAF, PIK3CA, AKT Gene Mutations, and MSI Status in Colorectal CancerBłażej Ochman, Anna Kot, Sylwia Mielcarska, et al.
Medicina (Kaunas, Lithuania)|December 24, 2021
The Concentration of CMKLR1 Expression on Clinicopathological Parameters of Colorectal Cancer: A Preliminary StudyPaweł Kiczmer, Sylwia Mielcarska, Magdalena Chrabańska, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Medicina (Kaunas, Lithuania)|January 21, 2022
Periostin in Angiogenesis and Inflammation in CRC-A Preliminary Observational StudyAgnieszka Kula, Miriam Dawidowicz, Sylwia Mielcarska, et al.
Cells|April 11, 2025
B7H3 in Gastrointestinal Tumors: Role in Immune Modulation and Cancer Progression: A Review of the LiteratureSylwia Mielcarska, Anna Kot, Agnieszka Kula, et al.
Medicina (Kaunas, Lithuania)|February 25, 2022
Assessment of the RANTES Level Correlation and Selected Inflammatory and Pro-Angiogenic Molecules Evaluation of Their Influence on CRC Clinical Features: A Preliminary Observational StudySylwia Mielcarska, Agnieszka Kula, Miriam Dawidowicz, et al.
Current Medical Science|June 25, 2021
GDF-15 Level Correlates with CMKLR1 and VEGF-A in Tumor-free Margin in Colorectal CancerSylwia Mielcarska, Kamila Stopińska, Miriam Dawidowicz, et al.
International Journal of Molecular Sciences|January 28, 2026
Association of TIGIT and CD155 with KRAS, NRAS, BRAF, PIK3CA, and AKT Gene Mutations, MSI Status, and Cytokine Profiles in Colorectal CancerBłażej Ochman, Piotr Limanówka, Sylwia Mielcarska, et al.
International Journal of Molecular Sciences|July 29, 2025
TIM-3/Galectin-9 Immune Axis in Colorectal Cancer in Relation to KRAS, NRAS, BRAF, PIK3CA, AKT1 Mutations, MSI Status, and the Cytokine MilieuBłażej Ochman, Anna Kot, Sylwia Mielcarska, et al.
Experimental and Molecular Pathology|January 14, 2020
Assessment of CMKLR1 level in colorectal cancer and its correlation with angiogenic markersPaweł Kiczmer, Alicja Prawdzic Seńkowska, Agnieszka Kula, et al.
Current Issues in Molecular Biology|May 15, 2023
Do Elevated YKL-40 Levels Drive the Immunosuppressive Tumor Microenvironment in Colorectal Cancer? Assessment of the Association of the Expression of YKL-40, MMP-8, IL17A, and PD-L1 with Coexisting Type 2 Diabetes, Obesity, and Active SmokingBłażej Ochman, Sylwia Mielcarska, Agnieszka Kula, et al.
Current Issues in Molecular Biology|December 27, 2024
Association of SIGLEC9 Expression with Cytokine Expression, Tumor Grading, KRAS, NRAS, BRAF, PIK3CA, AKT Gene Mutations, and MSI Status in Colorectal CancerBłażej Ochman, Anna Kot, Sylwia Mielcarska, et al.
Medicina (Kaunas, Lithuania)|December 24, 2021
The Concentration of CMKLR1 Expression on Clinicopathological Parameters of Colorectal Cancer: A Preliminary StudyPaweł Kiczmer, Sylwia Mielcarska, Magdalena Chrabańska, et al.
Pageof 3